เอเชีย

India Expands Under-Four Warning to All Chlorpheniramine–Phenylephrine Drug Combinations

อ่านข่าวนี้บน The State of Israel

เผยแพร่เมื่อ

Courtroom-sketch editorial illustration of a stethoscope from a 2012 photograph, with model lettering omitted; symbolic healthcare equipment, not the device, treatment, patient or facility reported.
AI courtroom sketch of a stethoscope from a 2012 photograph, with model lettering omitted; symbolic healthcare equipment, not the device, treatment, patient or facility reported. Adapted from the credited reference. Stethoscope No.120.JPG — Tama998; CC0.

India's Health Ministry has required every fixed-dose formulation containing chlorpheniramine maleate and phenylephrine hydrochloride to warn that it must not be used in children younger than four. The warning must appear on labels, package inserts and promotional literature. The notification, published in the Gazette on August 21, followed the Drugs Technical Advisory Board's February 16 recommendation.

แหล่งข้อมูล

แหล่งข้อมูลปฐมภูมิ:1

เรื่องที่เกี่ยวข้อง

  1. FDA Approves Mounjaro to Cut Cardiovascular Risk in High-Risk Adults With Type 2 Diabetes
  2. Gauteng Health Opens Probe Into Alleged Bribery and Queue-Jumping
  3. Australia Confirms Its First H5 Bird Flu Case in a Mammal, a Fur Seal in South Australia
  4. 112 Rwandan Police Officers Donate Blood for Patients
  5. Auckland Children’s Dental-Surgery Waitlist Falls by Two-Thirds

เกิดข้อผิดพลาด

เราไม่สามารถดำเนินการดังกล่าวได้ โปรดตรวจสอบการเชื่อมต่อของคุณแล้วลองใหม่อีกครั้ง